Company profile

JW Pharmaceutical

Diversified pharma

001060 · KRX · South Korea

Public Market Listing

001060KRX

KRX primary exchange listing

Live quotes, historical charts, and market capitalization for JW Pharmaceutical are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(5 total)
5Total Assets
1Approved
3Phase 3 / Filed
1Phase 1–2 / Early
4Diseases
Quick filter:
Showing 5 of 5 assets
Target & Modality
Anagliptin(Suiny)
Approved
DPP-4Small molecule
Type 2 Diabetes
C2402
Phase 3
Undisclosed / early pipelineSmall molecule
Hypertension
JW0201
Phase 3
Dipeptidyl peptidase-4 (DPP-4)Small molecule
Type 2 Diabetes
LivaloV(LivaloV)
Phase 3
HMG-CoA reductase / NPC1L1Small molecule
Atherosclerotic Cardiovascular Disease
CWP232291
Phase 1/2
Wnt/beta-catenin
Multiple Myeloma

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.